SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

SiRNA-circFARSA-loaded porous silicon nanomaterials for pancreatic cancer treatment via inhibition of CircFARSA expression

Published:2022-03 Issue: Volume:147 Page:112672
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Yuan Huixiao,Huang Xin,Li Qingqing,Luo Cici,Lin Chenyu,Zhang Shuxian,Zhang Yaguang,Yan Zhilin,Du Ning,Liu Zhongmin,Jiang Hua,Chen Bingdi

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference42 articles.

1. Cancer statistics, 2020;Siegel;CA Cancer J. Clin.,2020

2. Neoadjuvant therapy is associated with lower margin positivity rates after Pancreaticoduodenectomy in T1 and T2 pancreatic head cancers: an analysis of the National Cancer Database;Greco;Surg. Open Sci.,2020

3. Therapeutic developments in pancreatic cancer: current and future perspectives;Neoptolemos;Nat. Rev. Gastroenterol. Hepatol.,2018

4. Circular RNAs: isolation, characterization and their potential role in diseases;Liu;RNA Biol.,2017

5. Circular RNA participates in the carcinogenesis and the malignant behavior of cancer;Zhao;RNA Biol.,2017

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Growth mechanism of bismuth-filled nanoporous silicon with improved structural stability and low thermal conductivity;Results in Physics;2024-05

2. Recent advances in interface engineering of silicon anodes for enhanced lithium-ion battery performance;Energy Storage Materials;2024-02

3. PEG-modified nano liposomes co-deliver Apigenin and RAGE-siRNA to protect myocardial ischemia injury;International Journal of Pharmaceutics;2024-01

4. Cancer Bioenergetics and Tumor Microenvironments—Enhancing Chemotherapeutics and Targeting Resistant Niches through Nanosystems;Cancers;2023-07-28

5. Regulation of cisplatin resistance in bladder cancer by epigenetic mechanisms;Drug Resistance Updates;2023-05

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3